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Abstract
Background: Overweight and obesity are associated with many conditions treated in primary care. Our objectives
were: 1) to determine the frequency of weight-related conditions in a national sample of outpatient visits in the
United States; 2) to establish the percentage of diagnosis codes and visit codes attributable to overweight and
obesity; and 3) to estimate time spent to address these conditions, including time attributable to overweight and
obesity itself.
Methods: We analyzed primary care visits from the 2005 and 2006 National Ambulatory Medical Care Survey
(NAMCS) in the United States. Weight-related conditions included diabetes, hypertension, hyperlipidemia, obesity,
cardiovascular disease, osteoarthritis, and low back pain. We used multivariable logistic regression to estimate an
odds ratio for each weight-related condition, which we then converted to an attributable fraction (AF). The AF
represents the percentage of diagnosis codes and visit codes attributable to excess weight for that condition. We
then divided total visit time among all diagnoses and clinical items addressed at the primary care visit. Finally, to
calculate the time attributable to overweight and obesity, we multiplied the AFs by the time spent on each
weight-related condition.
Results: The total number of clinical items (diagnoses + medications + tests + counseling) was estimated to be 7.6
per patient, of which 2.2 were weight-related. Of a total visit time of 21.77 minutes, time spent addressing weight-
related conditions was 5.65 minutes (30%), including 1.75 minutes (8.0%) attributable to overweight and obesity.
Conclusions: Approximately 8% of time from primary care visits is attributable to overweight and obesity. This
estimate is conservative because the NAMCS only allows for coding of three diagnoses addressed per visit.
Estimates of the time burden of overweight and obesity provide data to prioritize weight management for
prevention and treatment.
Background
Excess weight (overweight and obesity) is associated
with an enormous burden of illness and is a root cause
for many conditions seen by primary care providers
(PCPs) [1,2]. For example, in the United States in 2005,
hypertension accounted for 28.1% of all office visits,
arthritis for 17.5%, diabetes for 11.9%, and depression
for 10.4% [3]. In spite of the importance of overweight/
obesity as a root cause for multiple medical problems,
PCPs are not consistently able to address weight man-
agement in all eligible patients. Barriers to the provision
of obesity treatment include the increasing complexity
of primary care visits [4-6] as well as limitations in time,
resources, training, and reimbursement [7-10].
PCPs clearly spend a significant portion of their time
diagnosing and treating conditions related to excess
weight. However, the time requirement has not been
quantified. Previous studies have estimated the burden
of obesity as the proportion of cases of a disease (e.g.,
diabetes) due to obesity or have estimated the percen-
tage of health care spending attributable to obesity
[11-14]. No study, however, has quantified the burden
of time faced by primary care clinicians. In the context
of a shortage of PCPs in the United States [15] and of
higher visit complexity, time spent on a prevalent condi-
tion (obesity) is of great importance to clinicians,
researchers, and policy makers.
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any medium, provided the original work is properly cited.The aims of this study were: 1) to estimate the num-
ber and prevalence of weight-related conditions in a
nationally representative sample of outpatient visits in
the United States; 2) to establish the percentage of diag-
nosis codes and visit codes attributable to overweight
and obesity; and 3) to estimate the amount of time
spent addressing these conditions. Our ultimate objec-
tive was to use the output from aims 2) and 3) above to
estimate the amount of primary care visit time attributa-
ble to overweight and to obesity.
Methods
The National Ambulatory Medical Care Survey
(NAMCS) is a nationally representative sample of outpa-
tient visits to physicians in the United States. NAMCS
uses a multi-stage sampling strategy, with providers
sampled randomly within defined geographic areas,
known as primary sampling units (PSUs). A PSU is
d e f i n e db yN A M C Sa sac o u n t yo rg r o u po fc o u n t i e s ,a
county equivalent (parish or independent city), a town
or township, or a metropolitan statistical area. Clinicians
and practice administrative staff enter information on a
one-page data collection form that includes: 1) up to
three diagnoses addressed at the visit; 2) chronic condi-
tions, whether addressed at the visit or not; 3) medica-
tions prescribed; 4) tests ordered; 5) non-medication
treatments recommended; and 6) counseling provided.
Height and weight are also collected on this form and
used to calculate body mass index (BMI). The data col-
lection form also includes patient socio-demographics
(age, gender, race and ethnicity, and insurance payer)
and a field for “time spent with provider”.N A M C S
includes visits to both generalist and specialist physi-
cians. The current analysis focused on visits to adult pri-
mary care physicians. These included visits listed under
general internal medicine, family medicine, geriatrics,
and general practice. All data in NAMCS are de-identi-
fied. Thus, the study was exempted from review by the
Colorado Multiple Institutional Review Board.
We defined the following diagnoses/diagnostic cate-
gories as weight-related: diabetes (type 2), hypertension;
hyperlipidemia; obesity; cardiovascular disease; depres-
sion; and musculoskeletal pain. Due to small sample sizes
for some diagnosis codes, the category of cardiovascular
disease was a composite of coronary artery disease, cere-
brovascular disease, peripheral arterial disease, chronic
kidney disease, and congestive heart failure. Similarly,
musculoskeletal pain was a composite of osteoarthritis
and low back pain. Because our goal was to divide visit
time among the diagnoses and other clinical items
addressed at the visit, we used only the field “diagnoses
related to this visit.” We did not use the field for chronic
conditions ("Regardless of the diagnoses written in [the
previous section], does the patient now have...”). We did
not use this latter field because we could not be certain
whether these conditions were addressed at the visit.
In addition to diagnosis codes, we counted subjects as
having received treatment for weight-related conditions
if a diagnosis was not coded but a medication was pre-
scribed at the visit. For example, if a diabetes medication
was prescribed but the diagnosis was not coded, we
counted diabetes as a secondary diagnosis. Finally, we
counted relevant diagnostic tests (e.g., hemoglobin A1c
test for diabetes) and counseling codes (e.g., weight
reduction counseling) under their respective conditions
if they were ordered/conducted at the visit. An appen-
dix, available on request from the first author, lists the
diagnoses, medications, tests, and counseling fields that
we included as weight-related.
A multivariable logistic regression model was con-
structed for each weight-related condition to estimate
the odds of receiving treatment for the condition (indi-
cated by a diagnosis code and/or a medication pre-
scribed) by category of body mass index (BMI). BMI
was categorized as normal weight (18.5-24.9 kg/m
2),
overweight (25-29.9 kg/m
2), or obese (≥ 30 kg/m
2)a n d
entered into the logistic regression as a categorical vari-
able. Individuals classified as underweight (BMI < 18.5
kg/m
2) were not included because of potential con-
founding by medical illness. Regressions also controlled
for patient age as a continuous variable, and for gender,
race/ethnicity, insurance payer (as a proxy for socioeco-
nomic status), number of previous visits during the past
12 months, and practice type (solo versus group) as
categorical variables. Additional logistic models were
constructed to estimate the odds of receiving each
weight-related diagnostic test or counseling item by
BMI category. The odds of receiving diagnostic tests
and counseling codes were estimated separately from
the diagnosis codes and medications because their asso-
ciation with overweight and obesity was substantially
weaker. The SAS/STAT
® procedure SURVEYLOGISTIC
was used to perform all analyses to include the NAMCS
sample weights and to account for the stratification and
clustering of the NAMCS sample design.
The logistic regression models were used to calculate
an attributable fraction (AF) separately for each weight-
related condition (diagnosis or medication), each
weight-related diagnostic test, and each weight-related
counseling code addressed at the office visit. The AF for
each of these clinical items [16] was calculated as:
OAF =1−
n
j=1 wjp(x0j, ˆ β)
n
j=1 wjp(xj, ˆ β)
,
where n is the number of patients, wj is the NAMCS
sample weight for the jth patient, p(x0j, ˆ β) is the model-
based predicted probability of the clinical item for
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individual was normal weight, and p(xj, ˆ β) is the pre-
dicted probability of the clinical item for each patient
given his or her covariates and observed obesity status.
The interpretation of the AF in this study is the follow-
ing: the percentage of weight-related clinical items (diag-
nosis/medication; diagnostic test; or counseling) that
can be attributed to overweight and obesity.T h i sd e f i n i -
tion is similar to that used in other epidemiologic ana-
lyses, in which the population attributable fraction, or
PAF, is most commonly interpreted as the percentage of
cases of a condition attributable to a given risk factor
[17]. One difference between standard estimates of attri-
butable risk and estimates from the current study is that
the former use population-based samples, whereas esti-
mates in this study are derived from a clinical popula-
tion. A second difference is that, until recently,
population attributable fractions in the obesity literature
were calculated using a formula that included only two
variables: the prevalence of the risk factor (e.g., obesity)
and the relative risk of a disease (e.g., diabetes) among
obese individuals, as compared to normal weight indivi-
duals [17]. This older formula does not control for pos-
sible confounding by other patient/subject
characteristics. By conducting multivariable regression
and converting the odds ratios to attributable fractions,
we believed our estimates would be more valid.
We summed the total number of clinical items
addressed at the office visit (including both weight-
related and non weight-related diagnoses + medications
+ tests + counseling), following a slightly adapted ver-
sion of published methods that have been previously
applied to NAMCS data [4]. To divide visit time among
these clinical items, we used the results of an empirical
study of recorded physician visits [18]. In that analysis,
half the time was spent addressing the primary diagno-
sis, and the remaining visit time was split among all
other clinical items discussed at the visit. We followed
this method, assigning half the time from the “Time
Spent with Provider” field in the NAMCS to the primary
diagnosis, and allocating the remaining time equally
among all secondary diagnoses and other clinical items.
The allocation of time described above provided an
estimate of the total time spent on each diagnosis or
clinical item. The last step in the analysis was to calcu-
late the time attributable to overweight and obesity.T o
do this, we multiplied the AFs (calculated from the
logistic regression models) by the total time spent on
each weight-related diagnosis/medication, test, or coun-
seling item. We then summed these times within each
condition (e.g., time spent addressing a diagnosis of dia-
betes + time spent prescribing medication for diabetes +
time spent ordering a hemoglobin A1c test).
Results
Table 1 shows the socio-demographic characteristics of
the study sample, stratified by BMI category. A total of
1,745 (26.7%) patients were normal weight, 2011 (30.7%)
were overweight, and 2612 (39.9%) were obese. An addi-
tional 181 (2.8%) individuals were underweight (BMI <
18.5 kg/m
2) and were excluded from further analysis.
Women comprised the majority of the sample and, rela-
tive to men, were more likely to be normal weight or
obese and less likely to be overweight. The percentage
of whites was lowest in the obese category and the per-
centages of African-Americans and Latinos were highest
in the obese category.
Table 2 lists the weight-related conditions included in
the analysis, the percent of the NAMCS sample that had
these diagnoses coded, and the estimated frequency of
office visits for these conditions in the United States.
Hypertension was coded nearly twice as commonly
(28.2% of visits) as the next nearest diagnoses, hyperlipi-
demia (16.7%) and musculoskeletal disorders (15.4%).
Diabetes was coded in 12.5% of visits, cardiovascular
disease and depression in 9-10%, and obesity in 3.5%. It
is estimated that over half (58.5%) of all adult patients
Table 1 Sample demographics of combined 2005-2006
NAMCS sample, excluding BMI < 18.5 kg/m
2*
BMI category† Normal
weight
(n = 1745)
Overweight
(n = 2011)
Obese
(n = 2612)
Age (mean ± SD) 50.7 ±
20.0
a
52.8 ±
17.3
b
51.1 ±
15.3
c
Body mass index, kg/m
2
(mean ± SD)
22.4 ± 1.7
a 27.4 ± 1.5
b 36.7 ± 6.6
c
Gender (%)
Female 64.7%
a 52.3%
b 58.7%
c
Male 35.3%
a 47.7%
b 41.3%
c
Race/Ethnicity (%)
Non-Hispanic White 69.9%
a 71.5%
a 65.8%
b
Non-Hispanic Black 11.6%
a 11.5%
a 15.7%
b
Hispanic 9.7%
ab 10.8%
b 12.3%
bc
Other or multi-racial 8.9%
a 6.1%
b 6.2%
b
Insurance payer (%)
Private insurance 47.3%
a 46.6%
a 46.9%
a
Medicare 22.8%
a 22.2%
a 18.0%
b
Medicaid 13.8%
a 12.8%
ab 15.0%
ac
Self-pay 6.5%
ab 7.9%
b 8.9%
bc
Other/unknown 9.7%
a 10.5%
a 11.3%
a
Time with Provider
(mean ± SD)
21.3 ± 11.6
a 22.0 ± 13.6
a 21.4 ±
12.4
a
* For pairwise comparisons: columns with different superscript are
significantly different from each other. T tests were used for continuous
variables (PROC SURVEY MEANS) and Rao-Scott Chi-Square tests (PROC
SURVEYFREQ) for categorical variables.
† Normal weight = 18.5-24.9 kg/m
2; overweight = 25-29.9 kg/m
2; obese = ≥
30 kg/m
2.
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treated for one of these weight-related conditions. The
total number of clinical items per patient (diagnoses +
medications + tests + counseling) was estimated (mean
± SE) to be 7.6 ± 0.11, of which 2.2 ± 0.11 were weight-
related items. The number of clinical items and of
weight-related clinical items increased with increasing
BMI category (normal weight, overweight, obese), parti-
cularly among the obese (7.1 ± 0.3, 7.2 ± 0.3, and 8.2 ±
0.2 respectively for all clinical items, p < 0.0001; 1.5 ±
0.1, 1.9 ± 0.1, and 2.8 ± 0.15 respectively for weight-
related items, p < 0.0001).
Table 3 shows the odds ratios for a diagnosis or medi-
cation being coded at the visit based on the presence of
overweight/obesity, as well as the corresponding AF.
Nearly 57% of diabetes diagnoses and/or medications
were attributable to overweight/obesity, as were 23-28%
of diagnoses and/or medications for hypertension,
hyperlipidemia, and cardiovascular disease. Coding of
depression was not significantly associated with over-
weight/obesity and thus fell out of additional analysis.
Nearly 89% of coded obesity diagnoses were attributable
to overweight or obesity. The percent of obesity diag-
noses attributable to overweight/obesity was not 100%,
possibly because: 1) a small number of patients were
misclassified due to measurement error (misreporting of
height and/or weight); or 2) the diagnosis was miscoded
on the data collection sheet. Attributable fractions in
the current analysis were consistent with previously
published population attributable fractions for common
weight-related conditions [14,19].
Table 4 shows the odds ratios and corresponding AFs
for diagnostic tests and counseling codes performed at
the visit. As noted above, the AFs for these codes were
smaller than those for diagnoses and medications (i.e., a
weaker association between overweight/obesity and
weight-related diagnostic tests or counseling codes). For
example, the AF for blood pressure screening was negli-
gible, even though the AF for a diagnosis or medication
for hypertension (Table 3) was 27.1%. This is because all
patients presenting for primary care undergo blood
pressure measurement, regardless of weight. A similar
analogy applies for cholesterol screening, which carried
a low AF. Diagnostic tests and counseling codes specific
to weight, however (e.g., weight reduction counseling),
had a high AF, in the same range as the AFs for coded
diagnoses and medications.
The Figure 1 shows the time spent per visit on each
weight-related condition, including the time attributable
to overweight/obesity for that condition. Time attributa-
ble to overweight/obesity for diabetes and hypertension
both accounted for an average of 0.4-0.5 minutes per
visit, and obesity accounted for an additional 0.4 min-
utes. The percentage of time attributable to overweight/
obesity for each condition corresponded roughly to the
AF listed in Table 3. The exception to this was obesity
itself, for which the AF in Table 3 was 88.7%, but the
percentage of time attributable was 44.4%. The lower
percentage is likely explained by the inclusion of coun-
seling codes (under the diagnosis category of obesity)
that are more common for overweight and obese
patients but are not limited to these patients. For exam-
ple, the AFs for diet/nutrition counseling and for exer-
cise counseling were 23.0% and 23.6%, respectively.
The total time spent on all weight-related conditions
was 5.65 minutes per visit, of which 1.75 minutes were
attributable to overweight and obesity (see Figure 1).
These 1.75 minutes accounted for 8.0% of the total
mean visit time in the NAMCS of 21.77 minutes - equal
to 38 minutes out of a hypothetical 8-hour work day. In
a secondary analysis where all patient visits in the sam-
ple were used to estimate the time spent treating each
condition (regardless of whether BMI was recorded),
overall results were similar - 40 minutes out of an 8-
Table 2 Number of cases, sample percentage, and estimated population percentage of patients receiving each
diagnosis or medication during the office visit (BMI recorded at office visit and excluding BMI < 18.5 kg/m
2
[N = 6,368])
Diagnosis or Medication Number of Cases % of Sample Estimated % of Patient Population (95% CI)
Hypertension 1,797 28.22 32.02 (28.55, 35.49)
Diabetes 793 12.45 11.73 (10.05, 13.41)
Hyperlipidemia 1,064 16.71 19.93 (17.15, 22.71)
*Musculoskeletal 978 15.36 20.83 (17.51, 24.14)
†Cardiovascular disease 617 9.69 12.48 (10.21, 14.76)
Depression 578 9.08 9.61 (7.82, 11.41)
‡Obesity 225 3.53 3.03 (2.12, 3.94)
Any above diagnosis or medication 3,473 54.54 58.44 (54.37, 62.53)
*Musculoskeletal: a composite diagnosis that included low back pain and osteoarthritis
†Cardiovascular disease: a composite diagnosis that included coronary artery disease, cerebrovascular disease, peripheral arterial disease, chronic kidney disease,
and congestive heart failure.
‡Obesity numbers and percentages based on diagnosis codes only.
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noses and clinical items (data not shown). Finally, in a
secondary analysis accounting for only the effect of obe-
sity (BMI ≥ 30 kg/m
2), total time attributable to weight-
related conditions was 23.5 minutes per day (4.9% of
total visit time).
Discussion
In this analysis of data from the NAMCS, we found that
excess weight accounts for 38 minutes, or 8% of an 8-
hour day for a primary care provider in the United
States. The 8% represents the amount of time spent to
evaluate and treat patients with weight-related condi-
tions that can be attributed to a single risk factor, excess
weight (i.e., overweight and obesity).W ec o n s i d e rt h i s
estimate to be conservative, for two reasons. First, we
elected to include only the three diagnoses addressed at
the visit but did not include other chronic conditions,
some of which likely would have been evaluated or
treated. Second, we could not account in this dataset for
several other weight-related diagnoses (e.g., uterine,
colon, and breast cancer, and gall bladder disease)
b e c a u s eo fi n a d e q u a t es a m p l es i z e sf o rm u l t i v a r i a b l e
analysis.
Although 8% is likely an underestimate, these results
offer a qualitatively different way to assess how over-
weight and obesity affect primary care medical practice.
The results suggest that, in a hypothetical situation
w h e r ea l lp a t i e n t sh a v eaB M I<2 5k g / m
2,P C P sw o u l d
have nearly 40 more minutes in their day. Forty minutes
would be enough to see 2 additional patients, or alterna-
tively, to spend a few more minutes with each patient to
improve quality of care (e.g., to raise cancer screening
rates). These results extend the work of Pearson et al,
who used NAMCS data and found that visits for obese
patients were slightly longer and involved a significantly
greater number of medications prescribed [20]. The
results also extend the work of Bertakis and Azari, who
Table 3 Odds ratios and attributable fractions (AFs) for receiving a diagnosis code or having a medication prescribed
during the office visit*
Diagnosis or Medication Number of Cases Estimated Population % Odds Ratio p-value AF
Diabetes
Normal 105 5.14 1.00 < 0.0001 56.67%
Overweight 182 8.04 1.60 (1.09, 2.35)
Obese 506 19.42 5.08 (3.57, 7.22)
Hypertension
Normal 350 22.84 1.00 < 0.0001 27.11%
Overweight 525 30.30 1.38 (1.08, 1.76)
Obese 922 39.98 2.50 (1.98, 3.14)
Hyperlipidemia
Normal 214 14.14 1.00 < 0.0001 28.36%
Overweight 365 20.33 1.46 (1.12, 1.90)
Obese 485 23.75 2.06 (1.55, 2.74)
Musculoskeletal
Normal 251 17.80 1.00 0.0005 13.10%
Overweight 296 19.71 1.07 (0.86, 1.34)
Obese 431 23.90 1.46 (1.19, 1.80)
Cardiovascular disease
Normal 139 9.71 1.00 0.0001 23.13%
Overweight 201 12.97 1.33 (1.02, 1.73)
Obese 277 14.07 1.78 (1.36, 2.34)
Depression
Normal 145 9.09 1.00
Overweight 182 9.40 1.15 (0.88, 1.49) 0.468 8.59%
Obese 251 10.16 1.16 (0.90, 1.48)
Obesity† 0, 1.00)
Normal 10 0.40 1.00 < 0.0001 88.68%
Overweight 35 1.16 3.83 (1.28, 11.48)
Obese 180 6.45 21.01 (5.92, 74.53)
*Logistic regression models adjusted for age, gender, race/ethnicity, insurance status, type of practice (solo or group), and number of past visits during the
previous 12 months. Regressions were limited to patients with BMI recorded at visit and excluded those with BMI < 18.5 kg/m
2.
†Obesity odds ratios and AFs based on diagnosis codes only.
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was not significantly related to visit length, but that phy-
sicians conducted more technical tasks (e.g., medication
prescribing) and less health education for their obese
patients [21]. Our results confirm the findings in these
two studies, and extend that work by estimating the
total amount of physician time required for these tasks
that can be attributed to overweight/obesity itself.
Attributable fractions have been used in previous
research to assign a proportion of cases of a disease or a
proportion of health care costs to obesity [14,19]. The
unique aspects of this study are: 1) the combination of
several methods that allowed us to estimate the burden
of time attributable to a single risk factor (excess
weight); and 2) the use of multivariable analysis to
address potential confounding in previous estimates of
attributable risk. The methods used in this study could
be replicated to estimate the burden of other health risk
factors (e.g., physical inactivity, alcohol or tobacco
abuse) that are associated with multiple medical
conditions.
This study has several limitations. First, only half of
t h eN A M C Ss a m p l eh a db o t hh e i g h ta n dw e i g h t
recorded on the data collection sheet, with the majority
Table 4 Odds ratios and obesity-attributable fractions (AFs) for clinical items*
Diagnosis Number of Cases Estimated Population % Odds Ratio p-value AF
(overweight + obese)
HbA1c
Normal 68 3.71 1.00 < 0.0001 38.72%
Overweight 94 4.27 1.09 (0.75, 1.58)
Obese 251 9.29 2.78 (1.93, 4.01)
Blood Pressure
Normal 1,704 97.15 1.00 0.569 0.05%
Overweight 1,957 96.91 0.92 (0.53, 1.58)
Obese 2,558 97.55 1.14 (0.69, 1.88)
Cholesterol
Normal 296 18.98 1.00 0.003 7.08%
Overweight 374 18.73 0.93 (0.75, 1.16)
Obese 540 23.08 1.33 (1.04, 1.69)
Diet/Nutrition
Normal 284 16.98 1.00 < 0.0001 23.04%
Overweight 404 19.09 1.15 (0.91, 1.44)
Obese 759 28.26 1.93 (1.55, 2.41)
Exercise
Normal 228 14.57 1.00 < 0.0001 23.61%
Overweight 327 17.12 1.22 (0.96, 1.54)
Obese 606 23.66 1.85 (1.41, 2.43)
Weight Reduction
Normal 26 1.3 1.00 < 0.0001 87.54%
Overweight 117 6.22 5.55 (2.51, 12.28)
Obese 496 19.22 19.27 (8.55, 43.44)
Depression
Normal 84 6.05 1.00 0.245 -24.58%
Overweight 78 4.06 0.73 (0.44, 1.21)
Obese 78 3.79 0.68 (0.42, 1.09)
EKG
Normal 81 6.86 1.00 0.430 -13.53%
Overweight 106 6.05 0.84 (0.55, 1.29)
Obese 113 5.26 0.80 (0.57, 1.13)
Physical Therapy
Normal 37 2.38 1.00 0.756 -6.71%
Overweight 37 2.37 0.99 (0.65, 1.50)
Obese 53 2.17 0.85 (0.54, 1.35)
*Regressions adjusted for age, gender, race/ethnicity, insurance status, solo vs. group practice, and number of visits in the previous 12 months. Regressions
limited to patients with recorded BMI, excluding BMI < 18.5 kg/m
2.
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Despite the limitations of BMI measurement, no signifi-
cant difference was observed between the weights of
those with and without height measured in the dataset
(183.4 lbs vs 183.3 lbs; p = 0.91). Thus, the measure-
ment of height (and the calculation of BMI) is not
biased towards heavier or towards lighter individuals.
NAMCS remains the best dataset available in the United
States to analyze the characteristics of a nationally
representative sample of primary care visits [22]. Sec-
ond, small sample sizes for some conditions necessitated
combining them. Attributable fractions (AFs) may not
be identical for some conditions that were combined (e.
g., low back pain and osteoarthritis). Third, our division
of time among diagnoses and clinical items at the visit
was based on a single empirical study of observed physi-
cian visits [18]. A study comparing NAMCS administra-
tive data with information from directly observed visits
reported that although PCPs in the United States over-
estimate visit duration, they also underestimate the
number of services provided within a visit [23]. Fourth,
these data are cross-sectional, and thus it is unknown
whether the obesity preceded (or followed) the diagnosis
codes used in the study.
Conclusions
This analysis is the first to quantify the time burden of
overweight and obesity. In a national sample of primary
care visits in the United States, we found that over-
weight and obesity accounted for 8% of provider time.
These results should be useful for clinicians, researchers,
and policy makers considering resource intensity of
weight loss interventions. For example, analyses of
weight loss interventions could use these results as an
estimate of provider time in a standard care group.
More broadly, increased attention to weight manage-
ment in clinical settings has been advocated as part of a
multi-faceted approach to the obesity epidemic [24,25].
Studies such as this provide data to facilitate the imple-
mentation of treatment.
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